ARTICLE | Company News
Shearwater to PEGylate Regeneron's Axokine
December 4, 2000 8:00 AM UTC
Shearwater (Huntsville, Ala.) will use its PEGylation technology to develop a PEGylated form of REGN's Axokine second generation ciliary neurotrophic factor ( CNTF) to treat obesity. Shearwater will r...